Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex311.htm |
| EX-23.1 - EXHIBIT 23.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex231.htm |
| EX-21.1 - EXHIBIT 21.1 - GENOCEA BIOSCIENCES, INC. | gnca-20161231xex211.htm |
| 10-K - 10-K - GENOCEA BIOSCIENCES, INC. | gnca-20161231x10k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Genocea Biosciences, Inc. (the “Company”) for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, Jonathan Poole, as the Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ JONATHAN POOLE | |
Jonathan Poole* | |
Chief Financial Officer | |
Date: February 17, 2017 | |
____________________________________
*A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.